Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
112 Cards in this Set
- Front
- Back
a dose wherein no additional analgesia is produced regardless of further dose increases
|
analgesic ceiling
|
|
transient moderate to severe pain that occurs above the pain treated by current analgesic treatment protocol
|
breakthrough pain
|
|
a property of a drug in which increasing the dose beyond an upper limit provides no greater analgesia
|
ceiling effect
|
|
the areas of skin innervated by the sensory fibers of a single dorsal root of a spinal nerve
|
dermatomes
|
|
a dose of one analgesic that is equivalent in pain-relieving effects to another analgesic
|
equianalgesic dose
|
|
the activation of descending pathways that exert inhibitory or faciliatory effects on the transmission of pain
|
modulation
|
|
pain caused by damage to nerve cells or changes in spinal cord processing
|
neuropathic pain
|
|
activation of the primary afferent nerves with peripheral terminals (free nerve endings) that respond to noxious (tissue-damaging) stimuli
|
nociception
|
|
pain that is caused by damage to somatic or visceral tissue and occurs abruptly after an injury or disease, persists until healing occurs, and often is intensified by anxiety or fear
|
nociceptive pain
|
|
an unpleasant sensory and emotional experience arising from actual or potential tissue damage and described in terms of such damage; whatever the person experiencing the pain says it is, existing whenever the person says it does
|
pain
|
|
an analgesic delivery system that allows the patient to receive a bolus infusion of an analgesic on demand within the parameters programmed into the delivery system
|
patient-controlled analgesia
|
|
the state in which pain is recognized, defined, and responded to by the individual experiencing the pain
|
perception
|
|
the state of severe distress associated with events that threaten the intactness of the person
|
suffering
|
|
dose adjustment based on assessment of the adequacy of analgesic effect versus the side effects produced
|
titration
|
|
the conversion of a mechanical, thermal, or chemical stimulus into a neuronal action potential
|
transduction
|
|
movement of pain impulses from the site of transduction to the brain
|
transmission
|
|
a circumscribed hypersensitive area within a tight band of muscle that is caused by acute or chronic muscle strain
|
trigger point
|
|
a potent mineralocorticoid secreted by the adrenal cortex that maintains extracellular fluid volume
|
aldosterone
|
|
a hormone released from the posterior pituitary gland that regulates fluid volume by stimulating reabsorption of water in the renal tubules
|
antidiuretic hormone
|
|
a hormone produced by the thyroid gland in response to high circulating calcium levels; acts to reduce the blood level of calcium and to inhibit bone resorption
|
calcitonin
|
|
a sympathomimetic compound composed of a catechol molecule and an amine from the amino acid tyrosine; includes epinephrine, norepinephrine, and dopamine; catecholamines secreted by the adrenal medulla are considered hormones; when released from nerve endings, they are considered neurotransmitters
|
catecholamine
|
|
any one of the glucocorticoid, mineralocorticoid, or androgen hormones secreted by the adrenal cortex
|
corticosteroid
|
|
the most abundant and potent glucocorticoid
|
cortisol
|
|
a hormone synthesized and released from pancreatic alpha cells in response to low levels of blood glucose, protein ingestion, and exercise
|
glucagon
|
|
an anterior pituitary hormone that affects the growth and development of skeletal muscles and long bones affecting a person's size and height
|
growth hormone
|
|
a chemical substance synthesized by a specific organ or tissue and secreted directly into the blood, where it is circulated to specific target tissues
|
hormone
|
|
an anabolic hormone secreted by the beta cells of the islets of Langerhans in the pancreas that is the principal regulator of the metabolism and storage of ingested carbohydrates, fats, and proteins
|
insulin
|
|
the hormone-secreting portion of the pancreas that includes alpha, beta, and delta cells
|
islets of Langerhans
|
|
a hormone-regulating mechanism in which there is a decrease or increase in hormone synthesis and secretion in response to a stimulus
|
negative feedback
|
|
hormone secreted by the parathyroid glands that regulates the blood level of calcium; acts to increase the blood level of calcium and to promote bone resorption
|
parathyroid hormone
|
|
a hormone regulating mechanism in which a high level of a substance stimulates hormone synthesis and secretion and a low level inhibits hormone synthesis and secretion
|
positive feedback
|
|
the body tissue or organ that the hormone affects
|
target tissue
|
|
the most abundant thyroid hormone; accounts for 90% of thyroid hormone produced by the thyroid gland
|
thyroxine (T4)
|
|
the more active thyroid hormone produced by the thyroid gland; 10% is secreted from the thyroid gland and the remainder is obtained by peripheral conversion of T4
|
triiodothyronine (T3)
|
|
a hormone secreted by one gland that stimulates another gland to synthesize and secrete its hormones (i.e., thyrotropin from the anterior pituitary gland stimulates the thyroid gland to synthesize and secrete thyroid hormones)
|
tropic hormone
|
|
a condition caused by excessive secretion of growth hormone characterized by an overgrowth of the bones and soft tissues
|
acromegaly
|
|
a life-threatening emergency caused by insufficient adrenocortical hormones or a sudden sharp decrease in these hormones; also known as an Addisonian crisis
|
acute adrenal insufficiency
|
|
the condition that exists when hypofunction of the adrenal cortex leads to (primary) adrenocortical insufficiency; a lack of pituitary ACTH secretion results in secondary adrenocortical insufficiency, not Addison's disease
|
Addison's disease
|
|
anterior pituitary hormone that stimulates growth of adrenal cortex and stimulates secretion of glucocorticoids
|
adrenocorticotropic hormone (ACTH)
|
|
hypothyroidism that develops in infancy
|
cretinism
|
|
a spectrum of clinical abnormalities caused by excess corticosteroids, particularly glucocorticoids
|
Cushing's syndrome
|
|
a group of conditions associated with a deficiency of production or secretion of ADH or a decreased renal response to ADH
|
diabetes insipidus
|
|
protrusion of the eyeballs from the orbits caused by increased fat deposits and fluid in the retroorbital tissues
|
exophthalmos (proptosis)
|
|
steroid hormones, primarily cortisol, produced by the adrenal cortex that affect glucose, protein, and fat metabolism and response to stress
|
glucocorticoids
|
|
enlargement of the thyroid gland that may be associated with hyperthyroidism, hypothyroidism, or normal thyroid function
|
goiter
|
|
food or drug that inhibits synthesis of thyroid hormones
|
goitrogen
|
|
an autoimmune disease of unknown etiology marked by diffuse thyroid enlargement and excessive thyroid hormone secretion
|
Graves' disease
|
|
excessive aldosterone secretion caused by an adenoma of the adrenal zona glomerulosa or bilateral adrenal hyperplasia
|
hyperaldosteronism
|
|
a condition involving increased secretion of parathyroid hormone (PTH) resulting in increased serum calcium levels
|
hyperparathyroidism
|
|
a hypermetabolic state caused by excessive circulating levels of T4, T3, or both; also referred to as thyrotoxicosis, thyrotoxic crisis, or thyroid storm
|
hyperthyroid crisis
|
|
a clinical syndrome where there is a sustained increase in synthesis and release of thyroid hormones by the thyroid gland
|
hyperthyroidism
|
|
a condition associated with inadequate circulating PTH
|
hypoparathyroidism
|
|
a rare disorder that involves a decrease in one or more of the pituitary hormones
|
hypopituitarism
|
|
insufficient circulation of thyroid hormones resulting in a hypometabolic state
|
hypothyroidism
|
|
steroid hormones, primarily aldosterone, produced by the adrenal cortex that maintain extracellular fluid volume; synthesis and secretion are stimulated by angiotensin II, hyponatremia, and hyperkalemia; inhibited by atrial natriuretic factor and hypokalemia
|
mineralocorticoids
|
|
the progression of the mental sluggishness, drowsiness, and lethargy of hypothyroidism to a notable impairment of consciousness or coma that is a medical emergency
|
myxedema
|
|
a rare condition characterized by a tumor of the adrenal medulla that produces excessive catecholamines (epinephrine, norepinephrine)
|
pheochromocytoma
|
|
adrenocortical insufficiency resulting from adrenal cortex dysfunction
|
primary adrenocortical insufficiency
|
|
adrenocortical insufficiency resulting from a lack of pituitary ACTH
|
secondary adrenocortical insufficiency
|
|
an abnormal production or sustained secretion of ADH despite normal or low plasma osmolarity that causes fluid retention, serum hypoosomolality, and dilutional hyponatremia
|
syndrome of inappropriate ADH (SIADH)
|
|
a condition of neuromuscular hyperexcitability associated with sudden decrease in calcium levels
|
tetany
|
|
an inflammation of the thyroid gland that may cause hyperthyroid or hypothyroid manifestations
|
thyroiditis
|
|
a hypermetabolic state caused by excessive circulating levels of T4, T3, or both; also referred to as thyrotoxic crisis, thyroid storm, or hyperthyroid crisis
|
thyrotoxicosis
|
|
uptake of nutrients from the gut lumen to the blood stream
|
absorption
|
|
a pigment derived from the breakdown of hemoglobin
|
bilirubin
|
|
audible abdominal sounds produced by hyperactive intestinal peristalsis
|
borborygmi
|
|
softening, fissuring, and cracking of lips at angles of mouth
|
cheilosis
|
|
the elimination of feces from the gastrointestinal tract through the rectum; involves a reflex action with voluntary and involuntary control
|
defecation
|
|
swallowing
|
deglutition
|
|
the physical and chemical breakdown of food into absorbable substances
|
digestion
|
|
the direct visualization of a body structure through a lighted instrument (scope)
|
endoscopy
|
|
vomiting of blood that indicates bleeding in the upper GI tract; may be bright red or of "coffee ground" character
|
hematemesis
|
|
liver cells
|
hepatocytes
|
|
taking in food
|
ingestion
|
|
macrophages found in the liver that remove bacteria and toxins from the blood
|
Kupffer cells
|
|
black, tarry stools that indicate slow bleeding from an upper GI source
|
melena
|
|
a discharge of purulent material
|
pyorrhea
|
|
burning in epigastric or substernal area; heartburn
|
pyrosis
|
|
bulky, foul-smelling, yellow-gray, greasy stools with puttylike consistency
|
steatorrhea
|
|
spasmodic contraction of the anal sphincter with pain and persistent desire to empty the bowel
|
tenesmus
|
|
a maneuver that involves contraction of the chest muscles on a closed glottis with simultaneous contraction of the abdominal muscles
|
Valsalva maneuver
|
|
minute, finger-like projections in the mucous membrane that are the functional units of the small intestine
|
villi
|
|
an acute inflammatory process of the pancreas
|
acute pancreatitis
|
|
accumulation of serous fluid in the peritoneal or abdominal cavity as a result of portal hypertension
|
ascites
|
|
flapping tremor (liver flap) commonly affecting the arms and hands that is a manifestation of hepatic encephalopathy
|
asterixis
|
|
digestion of tissues by their own secretions
|
autodigestion
|
|
Severe pain that is produced from spasms of the biliary ducts when gall stones are lodged in or move through the ducts
|
biliary colic
|
|
inflammation of the biliary ducts
|
cholangitis
|
|
surgical removal of the gallbladder
|
cholecystectomy
|
|
inflammation of the gallbladder
|
cholecystitis
|
|
calculi in the common bile duct
|
choledocholithiasis
|
|
stones in the gallbladder
|
cholelithiasis
|
|
progressive destruction of the pancreas with fibrotic replacement of pancreatic tissue
|
chronic pancreatitis
|
|
chronic, progressive disease of the liver characterized by extensive degeneration and destruction of the liver parenchymal cells
|
cirrhosis
|
|
distended, tortuous, fragile veins at the lower end of the esophagus that result from portal hypertension
|
esophageal varices
|
|
a musty, sweet odor of the patient's breath that occurs in some patients with hepatic encephalopathy
|
fetor hepaticus
|
|
a clinical syndrome that results in severe impairment or necrosis of liver cells and potential liver failure
|
fulminant viral hepatitis
|
|
Changes in neurologic and mental function resulting from high levels of ammonia in the blood that a damaged liver cannot detoxify
|
hepatic encephalopathy
|
|
inflammation of the liver
|
hepatitis
|
|
a serious complication of cirrhosis characterized by functional renal failure with advancing azotemia, oliguria, and intractable ascites
|
hepatorenal syndrome
|
|
term referring to jaundice
|
icteric
|
|
symptom of yellowish discoloration of body tissues that results from an increased concentration of bilirubin in the blood
|
jaundice
|
|
a large fluid-containing cavity within the pancreas resulting from extensive necrosis in the pancreas
|
pancreatic abscess
|
|
a cavity continuous with or surrounding the outside of the pancreas, filled with necrotic products and liquid secretions
|
pancreatic pseudocyst
|
|
a procedure in which fluid is withdrawn from a cavity of the body
|
paracentesis
|
|
increased venous pressure in the portal circulation caused by compression and destruction of the portal and hepatic veins and sinusoids resulting in splenomegaly, large collateral veins, ascites, systemic hypertension, and esophageal varices
|
portal hypertension
|
|
enzyme produced by the pancreas that causes hydrolysis of proteins
|
proteolytic enzyme
|
|
small, dilated blood vessels with a bright-red center point and spider-like branches
|
spider angiomas
|
|
metabolic product resulting from bacterial conversion of conjugated bilirubin in the bowel that gives the characteristic brown color to feces
|
stercobilinogen
|
|
a tube placed in the common bile duct during surgery when a common bile duct exploration is part of the surgical procedure; maintains patency of the duct until edema produced by the exploration subsides
|
T-tube
|
|
metabolic product resulting from bacterial conversion of conjugated bilirubin in the bowel, a very small amount of which is normally excreted in the urine
|
urobilinogen
|
|
inflammation of the liver caused by a variety of infectious viruses
|
viral hepatitis
|